Blog

Monday, April 27, 2015

Dr. Richard Fogel

Earlier this month I photographed Dr. Richard Fogel, a heart doctor at St. Vincent Heart Center in Indianapolis, for a Wall Street Journal story outlining a recent dramatic increase in the price of a pair of heart medications, Isuprel (Isoproterenol) and Nitropress (Nitroprusside Sodium). The price hikes were not a result of improvements but rather the ownership: the prices rose drastically after the rights to the drugs were acquired by Valeant Pharmaceuticals in earlier this year.

Richard Fogel

Dr. Richard Fogel poses for a portrait on Friday, April 3, 2015, at the St. Vincent Heart Center in Indianapolis. Ascension Health, which operates 131 hospitals across the country including St. Vincent, estimates price hikes to a pair of life-saving heart drugs, Isuprel (Isoproterenol) and Nitropress (Nitroprusside Sodium), will triple its spending on the medications this year. The price hikes were not a result of improvements but rather the ownership: the prices rose drastically after the rights to the drugs were acquired by Valeant Pharmaceuticals in February. (James Brosher for The Wall Street Journal)

Richard Fogel

Dr. Richard Fogel, right, speaks with a patient Deanna Chrysler, of West York, Ill., during an appointment on Friday, April 3, 2015, at the St. Vincent Heart Center in Indianapolis. (James Brosher for The Wall Street Journal)

Categories: News, Portraits | Tags: , | Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.